Abstract
We evaluated the reliability of disease-specific survival (DSS) as an outcome measure in patients with carcinoma of the prostate (CAP). The records of 50 patients had a diagnosis of CaP and had expired were selected from the hospital tumor registry. Records were reviewed by six individuals and each individual was asked to specify cause of death as due to CaP or some other cause. DSS curves were generated based on the determinations of each reviewer. Although the DSS curves were generally parallel, a high degree of variability was seen at various intervals, leading us to conclude that DSS is dependent upon the individual reviewer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 13-16 |
| Number of pages | 4 |
| Journal | Urologic Oncology: Seminars and Original Investigations |
| Volume | 4 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1998 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Oncology
- Urology
Fingerprint
Dive into the research topics of 'Interobserver variability in prostate cancer specific survival'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver